血液学市场规模、份额和成长分析（按产品类型、试剂类型、应用、最终用户和地区）- 产业预测，2025-2032 年

2023 年全球血液学市场规模价值 91.2 亿美元，预计将从 2024 年的 98.7 亿美元成长到 2032 年的 185.4 亿美元，预测期内（2025-2032 年）的复合年增长率为 8.2%。

全球血液学市场对于贫血、白血病、淋巴瘤和凝血障碍等血液疾病的诊断和监测至关重要。由于老化和生活方式因素导致这些疾病的盛行率不断上升，以及诊断技术的进步和新治疗方法的发展，是成长的主要动力。早期疾病检测和个人化医疗进一步推动了对先进血液分析仪的需求。然而，市场面临挑战，包括先进诊断设备成本高且严格的监管合规性。然而，人工智慧、机器学习、就地检验和远端医疗，这些技术可以帮助改善诊断服务的获取，特别是在资源有限的环境中，从而确保儘管存在障碍，但市场前景仍然强劲。

目录

介绍

• 调查目的
• 研究范围
• 定义

调查方法

• 资讯采购
• 次要和资料资料
• 市场规模预测
• 市场假设与限制

执行摘要

• 全球市场展望
• 供需趋势分析
• 细分市场机会分析

市场动态及展望

• 市场概况
• 市场规模
• 市场动态
  • 驱动因素和机会
  • 限制与挑战
• 波特的分析

主要市场考察

• 关键成功因素
• 竞争程度
• 主要投资机会
• 市场生态系统
• 市场吸引力指数（2024 年）
• PESTEL 分析
• 总体经济指标
• 价值链分析
• 定价分析
• 案例研究
• 监管格局
• 专利分析

血液学市场规模（按产品类型和复合年增长率） (2025-2032)

• 市场概况
• 血液分析仪
  • 三部分差异分析装置
  • 五分类分析仪
  • 照护现场分析仪
• 流式细胞仪
• 凝血分析仪
• 玻片染色设备
• 离心机
• 血红素测量仪
• 其他的

血液学市场规模（按试剂类型和复合年增长率） (2025-2032)

• 市场概况
• 凝血试剂
• 流式细胞技术试剂
• 免疫血液学试剂
• 其他的

血液学市场规模（按应用和复合年增长率） (2025-2032)

• 市场概况
• 贫血
• 血癌
• 血友病
• 感染
• 其他的

血液学市场规模（按最终用户和复合年增长率） (2025-2032)

• 市场概况
• 医院
• 诊断实验室
• 学术研究所
• 其他的

血液学市场规模（按地区）及复合年增长率（2025-2032）

• 北美洲
  • 美国
  • 加拿大
• 欧洲
  • 德国
  • 西班牙
  • 法国
  • 英国
  • 义大利
  • 其他欧洲国家
• 亚太地区
  • 中国
  • 印度
  • 日本
  • 韩国
  • 其他亚太地区
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲国家
• 中东和非洲
  • 海湾合作委员会国家
  • 南非
  • 其他中东和非洲地区

竞争资讯

• 前 5 家公司对比
• 主要企业市场定位（2024年）
• 主要市场参与者所采用的策略
• 近期市场趋势
• 公司市场占有率分析（2024 年）
• 主要企业简介
  • 公司简介
  • 产品系列分析
  • 按细分市场分析市场份额
  • 收益与前一年同期比较（2022-2024 年）

主要企业简介

• Roche（Switzerland）
• Merck & Co.（USA）
• Abbott Laboratories（USA）
• Takeda Pharmaceutical Company（Japan）
• Siemens Healthineers（Germany）
• Alexion Pharmaceuticals（USA）
• Sysmex Corporation（Japan）
• Novartis（Switzerland）
• Amgen（USA）
• Bristol-Myers Squibb（USA）
• Agilent Technologies（USA）
• Bio-Rad Laboratories（USA）
• Danaher Corporation（USA）
• Thermo Fisher Scientific（USA）
• Mindray（China）
• Beckman Coulter（USA）
• Horiba Ltd.（Japan）
• Boule Diagnostics AB（Sweden）
• Hoffmann-La Roche Ltd（Switzerland）

结论和建议

Global Hematology Market size was valued at USD 9.12 billion in 2023 and is poised to grow from USD 9.87 billion in 2024 to USD 18.54 billion by 2032, growing at a CAGR of 8.2% during the forecast period (2025-2032).

The global hematology market is essential for diagnosing and monitoring blood disorders such as anemia, leukemia, lymphoma, and coagulation issues. Significant growth is driven by the rising prevalence of these conditions, influenced by an aging population and lifestyle factors, alongside technological advancements in diagnostics and novel treatment developments. Early disease detection and personalized medicine further boost demand for advanced hematology analyzers. However, the market faces challenges, including the high cost of sophisticated diagnostic equipment and rigorous regulatory compliance. Yet, opportunities remain in technology integration, such as AI and machine learning, point-of-care testing, and telemedicine, facilitating improved access to diagnostic services, especially in resource-limited settings, promising a robust market outlook despite existing barriers.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Hematology market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Hematology Market Segmental Analysis

Global Hematology Market is segmented by Product Type, Reagent Type, Application, End User and region. Based on Product Type, the market is segmented into Hematology Analyzers, Flow Cytometers, Coagulation Analyzers, Slide Stainers, Centrifuges, Hemoglobinometers and Other. Based on Reagent Type, the market is segmented into Coagulation Reagents, Flow Cytometry Reagents, Immuno-Hematology Reagents and Other. Based on Application, the market is segmented into Anemia, Blood Cancer, Hemophilia, Infection and Other. Based on End User, the market is segmented into Hospitals, Diagnostic Laboratories, Academic and Research Institutes and Other. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Hematology Market

The growth of the global hematology market is significantly fueled by the rising prevalence of hematological disorders, including conditions like leukemia, lymphoma, and anemia. The World Health Organization reported a notable increase in anemia cases worldwide in 2022, highlighting an urgent demand for effective hematology diagnostics. This heightened incidence of blood-related diseases necessitates the use of advanced hematology analyzers capable of accurately measuring red blood cell counts and hemoglobin levels. Consequently, healthcare providers are seeking reliable diagnostic tools to manage the growing number of patients with these disorders, further propelling the expansion of the hematology sector in the global market.

Restraints in the Global Hematology Market

One of the significant restraints affecting the global hematology market is the high cost associated with advanced hematology equipment. Healthcare facilities, especially those in resource-constrained environments, often struggle to afford the substantial acquisition and maintenance expenses associated with state-of-the-art hematology analyzers and flow cytometers. Additionally, the financial burden of upgrading existing technology and training staff in using these sophisticated tools further complicates matters, creating barriers that hinder widespread adoption. As a result, these financial challenges significantly impact the overall growth and development of the hematology market, limiting accessibility and innovation.

Market Trends of the Global Hematology Market

The Global Hematology market is witnessing a significant trend towards the integration of Artificial Intelligence (AI) in diagnostics, predominantly shaping advancements in 2022 and beyond. AI technologies are revolutionizing blood analysis by enabling more precise identification of subtle abnormalities, which is crucial for accurate disease classification. This integration is enhancing the efficiency of hematology analyzers and flow cytometers while simultaneously processing vast datasets to deliver reliable results. Consequently, the adoption of AI is expected to drive market growth, improve diagnostic outcomes, and streamline workflows in laboratories, positioning AI as a pivotal component in the future of hematology diagnostics.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2024
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis
• Case Studies
• Regulatory Landscape
• Patent Analysis

Global Hematology Market Size by Product Type & CAGR (2025-2032)

• Market Overview
• Hematology Analyzers
  • 3-Part Differential Analyzers
  • 5-Part Differential Analyzers
  • Point-of-Care Analyzers
• Flow Cytometers
• Coagulation Analyzers
• Slide Stainers
• Centrifuges
• Hemoglobinometers
• Other

Global Hematology Market Size by Reagent Type & CAGR (2025-2032)

• Market Overview
• Coagulation Reagents
• Flow Cytometry Reagents
• Immuno-Hematology Reagents
• Other

Global Hematology Market Size by Application & CAGR (2025-2032)

• Market Overview
• Anemia
• Blood Cancer
• Hemophilia
• Infection
• Other

Global Hematology Market Size by End User & CAGR (2025-2032)

• Market Overview
• Hospitals
• Diagnostic Laboratories
• Academic and Research Institutes
• Other

Global Hematology Market Size & CAGR (2025-2032)

• North America (Product Type, Reagent Type, Application, End User)
  • US
  • Canada
• Europe (Product Type, Reagent Type, Application, End User)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Product Type, Reagent Type, Application, End User)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Product Type, Reagent Type, Application, End User)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Product Type, Reagent Type, Application, End User)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2024
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2024
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

• Roche (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Merck & Co. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Abbott Laboratories (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Takeda Pharmaceutical Company (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Siemens Healthineers (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Alexion Pharmaceuticals (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sysmex Corporation (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Novartis (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Amgen (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bristol-Myers Squibb (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Agilent Technologies (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bio-Rad Laboratories (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Danaher Corporation (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Thermo Fisher Scientific (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Mindray (China)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Beckman Coulter (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Horiba Ltd. (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Boule Diagnostics AB (Sweden)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Hoffmann-La Roche Ltd (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations